The effects of sertraline on severe tinnitus suffering - A randomized, double-blind, placebo-controlled study

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 32-39

  Zöger, Sigyn ^a   Svedlund, Jan ^a   Holgers, Kajsa Mia ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OXAZEPAM; PLACEBO; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK FACTOR; SCREENING TEST; SELF CONCEPT; TINNITUS; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; QUESTIONNAIRES; SERTRALINE; SEVERITY OF ILLNESS INDEX; TINNITUS; TREATMENT OUTCOME;

EID: 31544465718     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000195111.86650.19     Document Type: Article

References (60)

1. Axelsson A, Ringdahl A. Tinnitus - a study of its prevalence and characteristics. Br J Audiol. 1989;23:53-62.
2. Davis AC. Hearing in Adults. London, UK: Whurr; 1995.
3. Harrop-Griffiths J, Katon W, Dobie R, et al. Chronic tinnitus: association with psychiatric diagnosis. J Psychosom Res. 1987;31:613-621.
4. Sullivan MD, Katon W, Dobie R, et al. Disabling tinnitus. Association with affective disorder. Gen Hosp Psychiatry. 1988;10:285-291.
5. Holgers KM. Tinnitus Vårdprogram 2000. Stockholm, Sweden: Swedish National Board of Health and Welfare; 1999.
6. Zöger S, Svedlund J, Holgers KM. Psychiatric disorders in tinnitus patients without severe hearing impairment: 24 months follow-up of patients at an audiological clinic. Audiology. 2001;40:133-140.
7. Zöger S, Svedlund J, Holgers KM. Psychiatric profile of consecutive tinnitus patients with high risk of severe and chronic tinnitus suffering. Freemantle, Australia: Seventh International Tinnitus Seminar; March 2002.
8. Marciano E, Carrabba L, Giannini P, et al. Psychiatric comorbidity in a population of outpatients affected by tinnitus. Int J Audiol. 2003;42:4-9.
9. Holgers KM, Erlandsson S, Barrenäs ML. Predictive factors for the severity of tinnitus. Audiology. 2000;39:284-291.
10. Holgers KM, Zöger S, Svedlund J. Predictive factors for severe tinnitus suffering - further characterisation. Int J Audiol. 2005;44:584-592.
11. Dobie RA. Depression and tinnitus. Otolaryngol Clin North Am. 2003;36:383-388.
12. Holgers KM, Barrenäs ML. In: Luxon L, Furman JM, Martini A, et al, eds. The Pathophysiology and Assessment of Tinnitus. Textbook of Audiological Medicine: Clinical Aspects of Hearing and Balance. London, UK: Martin Dunitz Ltd; 2003:555-568.
13. Holgers KM. Mechanisms and classification of tinnitus - a discussion paper. Audiol Med. 2003;1:1-4.
14. Holgers KM, Svedlund J, Zöger S. Tinnitus suffering - a marker for a vulnerability in the serotonergic system? Audiol Med. 2003;2:138-143.
15. Folmer RL, Shi YB. SSRI use by tinnitus patients: interactions between depression and tinnitus severity. Ear Nose Throat J. 2004;83:107-108.
16. Dobie RA, Sullivan MD, Katon WJ, et al. Antidepressant treatment of tinnitus patients. Acta Otolaryngol. 1992;112:242-247.
17. Dobie R, Sakai CS, Sullivan MD, et al. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol. 1993;14:18-23.
18. Zohar J, Westenberg HG. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl. 2000;403:39-49.
19. van der Linden GJ, Stein DJ, van Balkom AJ. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials. Int Clin Psychopharmacol. August 2000;15(suppl 2):S15-S23.
20. Allgulander C, Dahl AA, Austin C, et al. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry. September 2004;161:1642-1649.
21. Ravindran AV, Judge R, Hunter BN, et al. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. J Clin Psychiatry. March 1997;58:112-118.
22. Sonawalla SB, Spillmann MK, Kolsky AR, et al. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. J Clin Psychiatry. September 1999;60:580-583.
23. Sonawalla SB, Farabaugh A, Johnson MW, et al. Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Int Clin Psychopharmacol. September 2002;16:215-219.
24. Russell JM, Koran LM, Rush J, et al. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety. 2001;13:18-27.
25. Rapaport MH, Wolkow R, Rubin A, et al. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. October 2001;104:289-298.
26. Hoehn-Saric R, Ninan P, Black DW, et al. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry. January 2000;57:76-82.
27. Waddell A, Canter R. Tinnitus. Clin Evid. 2003;10:634-643.
28. Robinson SK, Viirre ES, Stein MB. Antidepressant therapy for tinnitus. In: Snow, ed. Tinnitus: Theory and Management. Hamilton, Ontario, Canada: BC Decker Publ; 2004:1-15. [chapter 20].
29. Coles RRA, Lutman ME, Axelsson A, et al. Tinnitus severity gradings: cross-sectional studies. In: Aran JM, Dauman R, eds. Proc IVth Int Tinnitus Semin. Amsterdam/New York: Kugler Publ; 1991:453-455.
30. Baskill JL, Coles RRA, Lutman ME, et al. Tinnitus severity gradings: longitudinal studies. In: Aran JM, Dauman R, eds. Proc IVth Int Tinnitus Semin. Amsterdam/New York: Kugler Publ; 1991:457-460.
31. Axelsson A, Coles R, Erlandsson S, et al. Evaluation of tinnitus treatment: methodological aspects. J Audiol Med. 1993;2:141-150.
32. Holgers KM, Barrenäs ML, Svedlund J, et al. Clinical evaluation of tinnitus: a review. J Audiol Med. 2003;1:1-7.
33. First M, Gibbon M, Spitzer R, et al. Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I). New York: Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry, Columbia University; 1997. [Swedish translation] Box 42 Danderyd, Sweden: Pilgrim Press; 1998.
34. American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
35. Hamilton M. The assessment of anxiety states by rating. J Neurol Neurosurg Psychiatry. 1960;23:50-55.
36. The Hamilton Anxiety rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
37. Bech P, Malt UF, Dencker SJ, et al. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand. 1993;87(suppl 372):38, 43.
38. Åsberg M, Perris C, Sedvall G, et al. The CPRS - development and applications of a psychiatric rating scale. Acta Psychiatr Scand. 1978;271(suppl):5-27.
39. Svanborg P, Åsberg M. A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale. Acta Psychiatr Scand. 1994;89:21-28.
40. Martinsen EW, Friis S, Hoffart A. Assessment of depression: comparison between beck depression inventory and subscales of comprehensive psychopathological rating scale. Acta Psychiatr Scand. 1995;92:460-463.
41. Mattila-Evenden M, Svanborg P, Gustavsson P, et al. Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of the CPRS. Acta Psychiatr Scand. 1996;94:386-396.
42. Bradley JW. Distribution-Free Statistical Tests. London, UK: Prentice-Hall; 1968:68-86.
43. Odén A, Wedel H. Arguments for Fisher's permutation test. Ann Stat. 1975;3:518-520.
44. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity. A literature review. Arch Intern Med. 2003;163:2433-2444.
45. Murphy SL. Deaths: final data for 1998. National Vital Statistics Report, 48(11). DHHS Publication No. 2000-1120. Hyattsville, Md: National Center for Health Statistics; 2000.
46. Murray CJL, Lopez AD, eds. Summary: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Harvard University Press; 1996.
47. Cloninger CR. Comorbidity of anxiety and depression. J Clin Psychopharmacol. 1990;10(suppl 3):12-17.
48. Kellner M, Yehuda R. Do panic disorder and posttraumatic disorder share a common psychoneuroendocrinology? Psychoneuroendocrinology. 1999;24:485-504.
49. Kessler RC, Nelson CB, Gonagle KA. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry. 1996;168:17-30.
50. Gulley LR, Nemeroff CB. The neurobiological basis of mixed depression-anxiety states. J Clin Psychiatry. 1993;54:16-19.
51. Caspi A, Sugden K, Moffitt T, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
52. Kaufman J, Yang BZ, Douglas-Palumberi H, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A. November 2004;101:17316-17321.
53. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62:41-46.
54. Heim C, Newport J, Bonsall R, et al. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575-581.
55. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149:999-1010.
56. Bremner JD. Does stress damage the brain? Rec Adv Biol Psychiatry. 1999;45:797-805.
57. Baldwin D, Rudge S. The role of serotonin in depression and anxiety. Int Clin Psychopharmacol. 1995;9(suppl 4):41-45.
58. Jacobs BL, Praag van H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000;5: 262-269.
59. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12:2-19.
60. Gardner A, Pagani M, Jacobsson H, et al. Differences in resting state rCBF assessed with 99mTc-HMPAO SPECT and brain atlas matching between depressed patients with and without tinnitus. Nucl Med Commun. 2002;23:429-439.